Study Data
| Project uploaded by: | Neel Sarovar |
| Project ID: | IMP_100005 |
| Title: | A longitudinal pilot study on hemodynamically stable isolated chest trauma patients reveals sustained dysregulation of oxidative metabolism |
| Project Description: | Metabolomic dysregulation precedes clinical deterioration following injury. However, despite receiving comparable treatment, patients with similar injury severity often follow different clinical trajectories and outcomes. Metabolic profiling following an injury can aid in detecting systemic changes early and identifying novel biomarkers, enabling targeted interventions to improve patient outcomes. We hypothesized that metabolomic profiling in acutely injured patients would identify the perturbed metabolites and the physiological pathways within the first 72 hours of injury. Hence, this prospective study at a level 1 trauma centre analyzed the differentially regulated urine metabolites in patients with isolated blunt chest injuries and their longitudinal correlation with the severity of the injury. The study screened 1999 acutely injured patients with chest trauma between September 2019 and February 2023. Fifty hemodynamically stable patients with isolated chest trauma were recruited for the final analysis. Urine samples were collected on the injury's day 1, day 3, and day 7 day post-trauma. The study found that twenty metabolites were dysregulated in these patients (p-value <0.001). Twelve metabolites were upregulated, while the other eight showed downregulation. However, only five metabolites showed temporal association. These differentially regulated metabolites were involved in Glyoxylate and dicarboxylate metabolism pathways, glycine, serine, and threonine metabolism, and the Citrate cycle (TCA cycle). These metabolites could serve as biomarkers for early detection of systemic changes following chest injuries. |
| Research Area: | Biological Sciences |
| Funding Source: | ICGEB core funds, AIIMS core funds, SERB |
| Project Contributors: | Arun Kumar Malaisamy, Ramesh Vaidyanathan, Abhinav Kumar and Neel Sarovar Bhavesh |
| Study uploaded by: | Neel Sarovar |
| Study ID: | IMS_100005 |
| Title: | A longitudinal pilot study on hemodynamically stable isolated chest trauma patients reveals sustained dysregulation of oxidative metabolism |
| Summary: | Metabolomic dysregulation precedes clinical deterioration following injury. However, despite receiving comparable treatment, patients with similar injury severity often follow different clinical trajectories and outcomes. Metabolic profiling following an injury can aid in detecting systemic changes early and identifying novel biomarkers, enabling targeted interventions to improve patient outcomes. We hypothesized that metabolomic profiling in acutely injured patients would identify the perturbed metabolites and the physiological pathways within the first 72 hours of injury. Hence, this prospective study at a level 1 trauma centre analyzed the differentially regulated urine metabolites in patients with isolated blunt chest injuries and their longitudinal correlation with the severity of the injury. The study screened 1999 acutely injured patients with chest trauma between September 2019 and February 2023. Fifty hemodynamically stable patients with isolated chest trauma were recruited for the final analysis. Urine samples were collected on the injury's day 1, day 3, and day 7 day post-trauma. The study found that twenty metabolites were dysregulated in these patients (p-value <0.001). Twelve metabolites were upregulated, while the other eight showed downregulation. However, only five metabolites showed temporal association. These differentially regulated metabolites were involved in Glyoxylate and dicarboxylate metabolism pathways, glycine, serine, and threonine metabolism, and the Citrate cycle (TCA cycle). These metabolites could serve as biomarkers for early detection of systemic changes following chest injuries. |
| Keywords: | NMR spectroscopy, metabolomics, chest Trauma, oxidative metabolites, biomarker |
| Publication: | https://link.springer.com/article/10.1007/s11306-025-02241-3 |
| Release Date: | July 10, 2025 |
| Study Type: | Nuclear Magnetic Resonance (NMR) |
| Data Type: | Untargeted |
| IEC/IBSC Approval Number : | IEC-636/06.09.2019, and ICGEB/IEC/2020/23 |
| Sr.No | Sample ID | Sample Name | Organism | Source | Sample Preparation Protocol | Sample Type | Experimental Condition | Time of treatment | Variant/Variety | Gender | Age | Replicates | Storage Conditions | Extraction Protocol | Number of files per sample |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMSM_100610 | c1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 53 | N/A | -80 |
N/A |
||||
| 2 | IMSM_100611 | c10 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 17 | N/A | -80 |
N/A |
||||
| 3 | IMSM_100612 | c11 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 43 | N/A | -80 |
N/A |
||||
| 4 | IMSM_100613 | c12 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 52 | N/A | -80 |
N/A |
||||
| 5 | IMSM_100614 | c13 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 36 | N/A | -80 |
N/A |
||||
| 6 | IMSM_100615 | c14 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 53 | N/A | -80 |
N/A |
||||
| 7 | IMSM_100616 | c15 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 58 | N/A | -80 |
N/A |
||||
| 8 | IMSM_100617 | c16 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 43 | N/A | -80 |
N/A |
||||
| 9 | IMSM_100618 | c17 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 32 | N/A | -80 |
N/A |
||||
| 10 | IMSM_100619 | c18 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 43 | N/A | -80 |
N/A |
||||
| 11 | IMSM_100620 | c19 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 40 | N/A | -80 |
N/A |
||||
| 12 | IMSM_100621 | c2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 50 | N/A | -80 |
N/A |
||||
| 13 | IMSM_100622 | c20 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 45 | N/A | -80 |
N/A |
||||
| 14 | IMSM_100623 | c21 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 42 | N/A | -80 |
N/A |
||||
| 15 | IMSM_100624 | c22 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 45 | N/A | -80 |
N/A |
||||
| 16 | IMSM_100625 | c23 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 32 | N/A | -80 |
N/A |
||||
| 17 | IMSM_100626 | c24 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 44 | N/A | -80 |
N/A |
||||
| 18 | IMSM_100627 | c25 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 25 | N/A | -80 |
N/A |
||||
| 19 | IMSM_100628 | c26 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 40 | N/A | -80 |
N/A |
||||
| 20 | IMSM_100629 | c27 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 43 | N/A | -80 |
N/A |
||||
| 21 | IMSM_100630 | c28 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 42 | N/A | -80 |
N/A |
||||
| 22 | IMSM_100631 | c29 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 40 | N/A | -80 |
N/A |
||||
| 23 | IMSM_100632 | c3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 21 | N/A | -80 |
N/A |
||||
| 24 | IMSM_100633 | c30 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 38 | N/A | -80 |
N/A |
||||
| 25 | IMSM_100634 | c31 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 30 | N/A | -80 |
N/A |
||||
| 26 | IMSM_100635 | c32 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 21 | N/A | -80 |
N/A |
||||
| 27 | IMSM_100636 | c33 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 35 | N/A | -80 |
N/A |
||||
| 28 | IMSM_100637 | c34 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 32 | N/A | -80 |
N/A |
||||
| 29 | IMSM_100638 | c35 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 25 | N/A | -80 |
N/A |
||||
| 30 | IMSM_100639 | c36 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 40 | N/A | -80 |
N/A |
||||
| 31 | IMSM_100640 | c37 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 43 | N/A | -80 |
N/A |
||||
| 32 | IMSM_100641 | c38 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 42 | N/A | -80 |
N/A |
||||
| 33 | IMSM_100642 | c39 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 40 | N/A | -80 |
N/A |
||||
| 34 | IMSM_100643 | c4 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 21 | N/A | -80 |
N/A |
||||
| 35 | IMSM_100644 | c40 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 38 | N/A | -80 |
N/A |
||||
| 36 | IMSM_100645 | c41 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 30 | N/A | -80 |
N/A |
||||
| 37 | IMSM_100646 | c42 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 21 | N/A | -80 |
N/A |
||||
| 38 | IMSM_100647 | c43 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 35 | N/A | -80 |
N/A |
||||
| 39 | IMSM_100648 | c44 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 32 | N/A | -80 |
N/A |
||||
| 40 | IMSM_100649 | c45 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 46 | N/A | -80 |
N/A |
||||
| 41 | IMSM_100650 | c46 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 27 | N/A | -80 |
N/A |
||||
| 42 | IMSM_100651 | c47 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 35 | N/A | -80 |
N/A |
||||
| 43 | IMSM_100652 | c48 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 42 | N/A | -80 |
N/A |
||||
| 44 | IMSM_100653 | c49 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 30 | N/A | -80 |
N/A |
||||
| 45 | IMSM_100654 | c5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 50 | N/A | -80 |
N/A |
||||
| 46 | IMSM_100655 | c50 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 23 | N/A | -80 |
N/A |
||||
| 47 | IMSM_100656 | c6 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 43 | N/A | -80 |
N/A |
||||
| 48 | IMSM_100657 | c7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 42 | N/A | -80 |
N/A |
||||
| 49 | IMSM_100658 | c8 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 40 | N/A | -80 |
N/A |
||||
| 50 | IMSM_100659 | c9 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Healthy control | Male | 21 | N/A | -79 |
N/A |
||||
| 51 | IMSM_100660 | n10d0 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 52 | IMSM_100661 | n10d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 53 | IMSM_100662 | n10d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 54 | IMSM_100663 | n11a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 55 | IMSM_100664 | n11d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 56 | IMSM_100665 | n11d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 57 | IMSM_100666 | n12a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 58 | IMSM_100667 | n12d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 59 | IMSM_100668 | n12d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 60 | IMSM_100669 | n13a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 61 | IMSM_100670 | n13b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 62 | IMSM_100671 | n13b2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 63 | IMSM_100672 | n14a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 64 | IMSM_100673 | n14b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 65 | IMSM_100674 | n14c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 66 | IMSM_100675 | n15a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 67 | IMSM_100676 | n15b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 68 | IMSM_100677 | n15c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 69 | IMSM_100678 | n16d0 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 70 | IMSM_100679 | n16d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 71 | IMSM_100680 | n16d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 72 | IMSM_100681 | n17d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 73 | IMSM_100682 | n17d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 74 | IMSM_100683 | n17d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 75 | IMSM_100684 | n18a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 76 | IMSM_100685 | n18b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 77 | IMSM_100686 | n18c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 78 | IMSM_100687 | n19a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 38 | N/A | -80 |
N/A |
||||
| 79 | IMSM_100688 | n19b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 38 | N/A | -80 |
N/A |
||||
| 80 | IMSM_100689 | n19c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 38 | N/A | -80 |
N/A |
||||
| 81 | IMSM_100690 | n1a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 30 | N/A | -80 |
N/A |
||||
| 82 | IMSM_100691 | n1b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 30 | N/A | -80 |
N/A |
||||
| 83 | IMSM_100692 | n1c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 30 | N/A | -80 |
N/A |
||||
| 84 | IMSM_100693 | n20d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 45 | N/A | -80 |
N/A |
||||
| 85 | IMSM_100694 | n20d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 45 | N/A | -80 |
N/A |
||||
| 86 | IMSM_100695 | n20d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 45 | N/A | -80 |
N/A |
||||
| 87 | IMSM_100696 | n21d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 88 | IMSM_100697 | n21d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 89 | IMSM_100698 | n21d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 90 | IMSM_100699 | n22d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 91 | IMSM_100700 | n22d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 92 | IMSM_100701 | n22d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 93 | IMSM_100702 | n23d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 94 | IMSM_100703 | n23d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 95 | IMSM_100704 | n23d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 96 | IMSM_100705 | n24d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 46 | N/A | -80 |
N/A |
||||
| 97 | IMSM_100706 | n24d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 46 | N/A | -80 |
N/A |
||||
| 98 | IMSM_100707 | n24d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 46 | N/A | -80 |
N/A |
||||
| 99 | IMSM_100708 | n2a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 27 | N/A | -80 |
N/A |
||||
| 100 | IMSM_100709 | n2b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 27 | N/A | -80 |
N/A |
||||
| 101 | IMSM_100710 | n2c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 27 | N/A | -80 |
N/A |
||||
| 102 | IMSM_100711 | n3a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 103 | IMSM_100712 | n3b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 104 | IMSM_100713 | n3c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 105 | IMSM_100714 | n4a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 106 | IMSM_100715 | n4b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 107 | IMSM_100716 | n4c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 108 | IMSM_100717 | n5a | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 18 | N/A | -80 |
N/A |
||||
| 109 | IMSM_100718 | n5b | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 18 | N/A | -80 |
N/A |
||||
| 110 | IMSM_100719 | n5c | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 18 | N/A | -80 |
N/A |
||||
| 111 | IMSM_100720 | n7D1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 44 | N/A | -80 |
N/A |
||||
| 112 | IMSM_100721 | n7d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 44 | N/A | -80 |
N/A |
||||
| 113 | IMSM_100722 | n7d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 44 | N/A | -80 |
N/A |
||||
| 114 | IMSM_100723 | n8d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 115 | IMSM_100724 | n8d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 116 | IMSM_100725 | n8d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 117 | IMSM_100726 | n9d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 25 | N/A | -80 |
N/A |
||||
| 118 | IMSM_100727 | n9d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 25 | N/A | -80 |
N/A |
||||
| 119 | IMSM_100728 | n9d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 25 | N/A | -80 |
N/A |
||||
| 120 | IMSM_100729 | p10d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 121 | IMSM_100730 | p10d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 122 | IMSM_100731 | p10d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 123 | IMSM_100732 | p11d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 124 | IMSM_100733 | p11d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 125 | IMSM_100734 | p11d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 126 | IMSM_100735 | p12d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 127 | IMSM_100736 | p12d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 128 | IMSM_100737 | p12d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 129 | IMSM_100738 | p14d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 130 | IMSM_100739 | p14d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 131 | IMSM_100740 | p14d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 36 | N/A | -80 |
N/A |
||||
| 132 | IMSM_100741 | p15d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 133 | IMSM_100742 | p15d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 134 | IMSM_100743 | p15d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 135 | IMSM_100744 | p16d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 53 | N/A | -80 |
N/A |
||||
| 136 | IMSM_100745 | p16d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 53 | N/A | -80 |
N/A |
||||
| 137 | IMSM_100746 | p16d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 53 | N/A | -80 |
N/A |
||||
| 138 | IMSM_100747 | p17d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 30 | N/A | -80 |
N/A |
||||
| 139 | IMSM_100748 | p17d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 30 | N/A | -80 |
N/A |
||||
| 140 | IMSM_100749 | p17d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 30 | N/A | -80 |
N/A |
||||
| 141 | IMSM_100750 | p18d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 58 | N/A | -80 |
N/A |
||||
| 142 | IMSM_100751 | p18d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 58 | N/A | -80 |
N/A |
||||
| 143 | IMSM_100752 | p18d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 58 | N/A | -80 |
N/A |
||||
| 144 | IMSM_100753 | p19d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 145 | IMSM_100754 | p19d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 146 | IMSM_100755 | p19d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 147 | IMSM_100756 | p1d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 148 | IMSM_100757 | p1d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 149 | IMSM_100758 | p1d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 150 | IMSM_100759 | p20d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 151 | IMSM_100760 | p20d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 152 | IMSM_100761 | p20d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 35 | N/A | -80 |
N/A |
||||
| 153 | IMSM_100762 | p21d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 23 | N/A | -80 |
N/A |
||||
| 154 | IMSM_100763 | p21d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 23 | N/A | -80 |
N/A |
||||
| 155 | IMSM_100764 | p21d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 23 | N/A | -80 |
N/A |
||||
| 156 | IMSM_100765 | p23d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 157 | IMSM_100766 | p23d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 158 | IMSM_100767 | p23d5 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 159 | IMSM_100768 | p24d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 26 | N/A | -80 |
N/A |
||||
| 160 | IMSM_100769 | p24d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 26 | N/A | -80 |
N/A |
||||
| 161 | IMSM_100770 | p24d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 26 | N/A | -80 |
N/A |
||||
| 162 | IMSM_100771 | p25d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 163 | IMSM_100772 | p25d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 164 | IMSM_100773 | p25d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 21 | N/A | -80 |
N/A |
||||
| 165 | IMSM_100774 | p26d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 166 | IMSM_100775 | p26d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 167 | IMSM_100776 | p26d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 43 | N/A | -80 |
N/A |
||||
| 168 | IMSM_100777 | p27d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 64 | N/A | -80 |
N/A |
||||
| 169 | IMSM_100778 | p27d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 64 | N/A | -80 |
N/A |
||||
| 170 | IMSM_100779 | p27d7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 64 | N/A | -80 |
N/A |
||||
| 171 | IMSM_100780 | p28d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 172 | IMSM_100781 | p28d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 173 | IMSM_100782 | p28d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 40 | N/A | -80 |
N/A |
||||
| 174 | IMSM_100783 | p29d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 175 | IMSM_100784 | p29d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 176 | IMSM_100785 | p29d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 177 | IMSM_100786 | p2d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 70 | N/A | -80 |
N/A |
||||
| 178 | IMSM_100787 | p2d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 70 | N/A | -80 |
N/A |
||||
| 179 | IMSM_100788 | p2d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 70 | N/A | -80 |
N/A |
||||
| 180 | IMSM_100789 | p30d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 45 | N/A | -80 |
N/A |
||||
| 181 | IMSM_100790 | p30d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 45 | N/A | -80 |
N/A |
||||
| 182 | IMSM_100791 | p30d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 45 | N/A | -80 |
N/A |
||||
| 183 | IMSM_100792 | p31d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 184 | IMSM_100793 | p31d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 185 | IMSM_100794 | p31d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 52 | N/A | -80 |
N/A |
||||
| 186 | IMSM_100795 | p32d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 187 | IMSM_100796 | p32d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 188 | IMSM_100797 | p32d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 42 | N/A | -80 |
N/A |
||||
| 189 | IMSM_100798 | p3d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 190 | IMSM_100799 | p3d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 191 | IMSM_100800 | p3d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 50 | N/A | -80 |
N/A |
||||
| 192 | IMSM_100801 | p4d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 193 | IMSM_100802 | p4d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 194 | IMSM_100803 | p4d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 32 | N/A | -80 |
N/A |
||||
| 195 | IMSM_100804 | p7ad1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 53 | N/A | -80 |
N/A |
||||
| 196 | IMSM_100805 | p7ad2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 53 | N/A | -80 |
N/A |
||||
| 197 | IMSM_100806 | p7ad7 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 53 | N/A | -80 |
N/A |
||||
| 198 | IMSM_100807 | p7d1 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 17 | N/A | -80 |
N/A |
||||
| 199 | IMSM_100808 | p7d2 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 17 | N/A | -80 |
N/A |
||||
| 200 | IMSM_100809 | p7d3 | Homo sapiens | Urine | The urine samples were thawed during NMR measurements, and 0.5 ml of urine samples were transferred to a 1.5 ml centrifuge tube to eliminate contaminants of larger molecules. The samples were centrifuged at 10000g at 4 °C for 10 minutes to remove solid debris. Next, 180 µl of urine samples in the supernatant (metabolite) were transferred to a fresh centrifuge tube, and 20 µl NMR buffer (1.5 M KH2PO4, 2 mM NaN3, 5.8 mM sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 in D2O pH 7.4) was gently mixed. The resulting solutions were transferred to separate 3 mm NMR tubes. | Trauma patients | Male | 17 | N/A | -80 |
N/A |
| Sr.No | NMR Exp ID | Sample Name/ID | Reference Standard | NMR Instrument Name | NMR Instrument Type | NMR Experiment Type | NMR Spectrometer Frequency | NMR Probe | NMR Probe temperature | NMR Solvent | NMR tube size | Data Transformation (Software/s Used) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IME_100067 | c1 / IMSM_100610 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 2 | IME_100068 | c10 / IMSM_100611 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 3 | IME_100069 | c11 / IMSM_100612 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 4 | IME_100070 | c12 / IMSM_100613 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 5 | IME_100071 | c13 / IMSM_100614 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 6 | IME_100072 | c14 / IMSM_100615 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 7 | IME_100073 | c15 / IMSM_100616 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 8 | IME_100074 | c16 / IMSM_100617 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 9 | IME_100075 | c17 / IMSM_100618 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 10 | IME_100076 | c18 / IMSM_100619 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 11 | IME_100077 | c19 / IMSM_100620 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 12 | IME_100078 | c2 / IMSM_100621 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 13 | IME_100079 | c20 / IMSM_100622 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 14 | IME_100080 | c21 / IMSM_100623 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 15 | IME_100081 | c22 / IMSM_100624 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 16 | IME_100082 | c23 / IMSM_100625 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 17 | IME_100083 | c24 / IMSM_100626 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 18 | IME_100084 | c25 / IMSM_100627 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 19 | IME_100085 | c26 / IMSM_100628 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 20 | IME_100086 | c27 / IMSM_100629 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 21 | IME_100087 | c28 / IMSM_100630 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 22 | IME_100088 | c29 / IMSM_100631 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 23 | IME_100089 | c3 / IMSM_100632 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 24 | IME_100090 | c30 / IMSM_100633 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 25 | IME_100091 | c31 / IMSM_100634 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 26 | IME_100092 | c32 / IMSM_100635 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 27 | IME_100093 | c33 / IMSM_100636 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 28 | IME_100094 | c34 / IMSM_100637 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 29 | IME_100095 | c35 / IMSM_100638 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 30 | IME_100096 | c36 / IMSM_100639 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 31 | IME_100097 | c37 / IMSM_100640 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 32 | IME_100098 | c38 / IMSM_100641 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 33 | IME_100099 | c39 / IMSM_100642 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 34 | IME_100100 | c4 / IMSM_100643 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 35 | IME_100101 | c40 / IMSM_100644 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 36 | IME_100102 | c41 / IMSM_100645 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 37 | IME_100103 | c42 / IMSM_100646 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 38 | IME_100104 | c43 / IMSM_100647 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 39 | IME_100105 | c44 / IMSM_100648 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 40 | IME_100106 | c45 / IMSM_100649 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 41 | IME_100107 | c46 / IMSM_100650 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 42 | IME_100108 | c47 / IMSM_100651 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 43 | IME_100109 | c48 / IMSM_100652 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 44 | IME_100110 | c49 / IMSM_100653 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 45 | IME_100111 | c5 / IMSM_100654 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 46 | IME_100112 | c50 / IMSM_100655 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 47 | IME_100113 | c6 / IMSM_100656 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 48 | IME_100114 | c7 / IMSM_100657 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 49 | IME_100115 | c8 / IMSM_100658 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 50 | IME_100116 | c9 / IMSM_100659 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 51 | IME_100117 | n10d0 / IMSM_100660 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 52 | IME_100118 | n10d1 / IMSM_100661 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 53 | IME_100119 | n10d3 / IMSM_100662 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 54 | IME_100120 | n11a / IMSM_100663 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 55 | IME_100121 | n11d1 / IMSM_100664 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 56 | IME_100122 | n11d5 / IMSM_100665 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 57 | IME_100123 | n12a / IMSM_100666 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 58 | IME_100124 | n12d1 / IMSM_100667 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 59 | IME_100125 | n12d5 / IMSM_100668 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 60 | IME_100126 | n13a / IMSM_100669 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 61 | IME_100127 | n13b / IMSM_100670 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 62 | IME_100128 | n13b2 / IMSM_100671 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 63 | IME_100129 | n14a / IMSM_100672 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 64 | IME_100130 | n14b / IMSM_100673 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 65 | IME_100131 | n14c / IMSM_100674 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 66 | IME_100132 | n15a / IMSM_100675 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 67 | IME_100133 | n15b / IMSM_100676 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 68 | IME_100134 | n15c / IMSM_100677 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 69 | IME_100135 | n16d0 / IMSM_100678 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 70 | IME_100136 | n16d1 / IMSM_100679 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 71 | IME_100137 | n16d7 / IMSM_100680 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 72 | IME_100138 | n17d1 / IMSM_100681 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 73 | IME_100139 | n17d3 / IMSM_100682 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 74 | IME_100140 | n17d5 / IMSM_100683 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 75 | IME_100141 | n18a / IMSM_100684 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 76 | IME_100142 | n18b / IMSM_100685 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 77 | IME_100143 | n18c / IMSM_100686 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 78 | IME_100144 | n19a / IMSM_100687 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 79 | IME_100145 | n19b / IMSM_100688 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 80 | IME_100146 | n19c / IMSM_100689 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 81 | IME_100147 | n1a / IMSM_100690 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 82 | IME_100148 | n1b / IMSM_100691 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 83 | IME_100149 | n1c / IMSM_100692 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 84 | IME_100150 | n20d1 / IMSM_100693 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 85 | IME_100151 | n20d3 / IMSM_100694 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 86 | IME_100152 | n20d5 / IMSM_100695 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 87 | IME_100153 | n21d1 / IMSM_100696 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 88 | IME_100154 | n21d3 / IMSM_100697 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 89 | IME_100155 | n21d7 / IMSM_100698 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 90 | IME_100156 | n22d1 / IMSM_100699 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 91 | IME_100157 | n22d3 / IMSM_100700 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 92 | IME_100158 | n22d5 / IMSM_100701 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 93 | IME_100159 | n23d1 / IMSM_100702 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 94 | IME_100160 | n23d2 / IMSM_100703 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 95 | IME_100161 | n23d7 / IMSM_100704 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 96 | IME_100162 | n24d1 / IMSM_100705 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 97 | IME_100163 | n24d3 / IMSM_100706 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 98 | IME_100164 | n24d7 / IMSM_100707 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 99 | IME_100165 | n2a / IMSM_100708 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 100 | IME_100166 | n2b / IMSM_100709 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 101 | IME_100167 | n2c / IMSM_100710 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 102 | IME_100168 | n3a / IMSM_100711 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 103 | IME_100169 | n3b / IMSM_100712 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 104 | IME_100170 | n3c / IMSM_100713 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 105 | IME_100171 | n4a / IMSM_100714 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 106 | IME_100172 | n4b / IMSM_100715 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 107 | IME_100173 | n4c / IMSM_100716 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 108 | IME_100174 | n5a / IMSM_100717 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 109 | IME_100175 | n5b / IMSM_100718 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 110 | IME_100176 | n5c / IMSM_100719 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 111 | IME_100177 | n7D1 / IMSM_100720 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 112 | IME_100178 | n7d3 / IMSM_100721 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 113 | IME_100179 | n7d5 / IMSM_100722 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 114 | IME_100180 | n8d1 / IMSM_100723 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 115 | IME_100181 | n8d3 / IMSM_100724 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 116 | IME_100182 | n8d5 / IMSM_100725 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 117 | IME_100183 | n9d1 / IMSM_100726 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 118 | IME_100184 | n9d3 / IMSM_100727 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 119 | IME_100185 | n9d5 / IMSM_100728 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 120 | IME_100186 | p10d1 / IMSM_100729 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 121 | IME_100187 | p10d2 / IMSM_100730 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 122 | IME_100188 | p10d3 / IMSM_100731 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 123 | IME_100189 | p11d1 / IMSM_100732 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 124 | IME_100190 | p11d2 / IMSM_100733 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 125 | IME_100191 | p11d3 / IMSM_100734 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 126 | IME_100192 | p12d1 / IMSM_100735 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 127 | IME_100193 | p12d2 / IMSM_100736 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 128 | IME_100194 | p12d3 / IMSM_100737 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 129 | IME_100195 | p14d2 / IMSM_100738 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 130 | IME_100196 | p14d3 / IMSM_100739 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 131 | IME_100197 | p14d7 / IMSM_100740 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 132 | IME_100198 | p15d1 / IMSM_100741 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 133 | IME_100199 | p15d2 / IMSM_100742 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 134 | IME_100200 | p15d7 / IMSM_100743 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 135 | IME_100201 | p16d1 / IMSM_100744 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 136 | IME_100202 | p16d2 / IMSM_100745 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 137 | IME_100203 | p16d3 / IMSM_100746 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 138 | IME_100204 | p17d1 / IMSM_100747 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 139 | IME_100205 | p17d2 / IMSM_100748 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 140 | IME_100206 | p17d3 / IMSM_100749 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 141 | IME_100207 | p18d1 / IMSM_100750 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 142 | IME_100208 | p18d2 / IMSM_100751 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 143 | IME_100209 | p18d3 / IMSM_100752 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 144 | IME_100210 | p19d1 / IMSM_100753 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 145 | IME_100211 | p19d2 / IMSM_100754 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 146 | IME_100212 | p19d7 / IMSM_100755 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 147 | IME_100213 | p1d1 / IMSM_100756 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 148 | IME_100214 | p1d2 / IMSM_100757 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 149 | IME_100215 | p1d3 / IMSM_100758 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 150 | IME_100216 | p20d1 / IMSM_100759 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 151 | IME_100217 | p20d2 / IMSM_100760 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 152 | IME_100218 | p20d7 / IMSM_100761 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 153 | IME_100219 | p21d1 / IMSM_100762 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 154 | IME_100220 | p21d2 / IMSM_100763 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 155 | IME_100221 | p21d3 / IMSM_100764 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 156 | IME_100222 | p23d1 / IMSM_100765 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 157 | IME_100223 | p23d2 / IMSM_100766 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 158 | IME_100224 | p23d5 / IMSM_100767 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 159 | IME_100225 | p24d1 / IMSM_100768 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 160 | IME_100226 | p24d2 / IMSM_100769 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 161 | IME_100227 | p24d7 / IMSM_100770 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 162 | IME_100228 | p25d1 / IMSM_100771 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 163 | IME_100229 | p25d2 / IMSM_100772 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 164 | IME_100230 | p25d3 / IMSM_100773 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 165 | IME_100231 | p26d1 / IMSM_100774 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 166 | IME_100232 | p26d2 / IMSM_100775 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 167 | IME_100233 | p26d3 / IMSM_100776 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 168 | IME_100234 | p27d1 / IMSM_100777 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 169 | IME_100235 | p27d2 / IMSM_100778 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 170 | IME_100236 | p27d7 / IMSM_100779 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 171 | IME_100237 | p28d1 / IMSM_100780 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 172 | IME_100238 | p28d2 / IMSM_100781 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 173 | IME_100239 | p28d3 / IMSM_100782 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 174 | IME_100240 | p29d1 / IMSM_100783 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 175 | IME_100241 | p29d2 / IMSM_100784 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 176 | IME_100242 | p29d3 / IMSM_100785 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 177 | IME_100243 | p2d1 / IMSM_100786 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 178 | IME_100244 | p2d2 / IMSM_100787 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 179 | IME_100245 | p2d3 / IMSM_100788 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 180 | IME_100246 | p30d1 / IMSM_100789 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 181 | IME_100247 | p30d2 / IMSM_100790 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 182 | IME_100248 | p30d3 / IMSM_100791 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 183 | IME_100249 | p31d1 / IMSM_100792 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 184 | IME_100250 | p31d2 / IMSM_100793 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 185 | IME_100251 | p31d3 / IMSM_100794 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 186 | IME_100252 | p32d1 / IMSM_100795 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 187 | IME_100253 | p32d2 / IMSM_100796 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 188 | IME_100254 | p32d3 / IMSM_100797 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 189 | IME_100255 | p3d1 / IMSM_100798 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 190 | IME_100256 | p3d2 / IMSM_100799 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 191 | IME_100257 | p3d3 / IMSM_100800 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 192 | IME_100258 | p4d1 / IMSM_100801 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 193 | IME_100259 | p4d2 / IMSM_100802 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 194 | IME_100260 | p4d3 / IMSM_100803 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 195 | IME_100261 | p7ad1 / IMSM_100804 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 196 | IME_100262 | p7ad2 / IMSM_100805 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 197 | IME_100263 | p7ad7 / IMSM_100806 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 198 | IME_100264 | p7d1 / IMSM_100807 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 199 | IME_100265 | p7d2 / IMSM_100808 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| 200 | IME_100266 | p7d3 / IMSM_100809 | DSS | Bruker Avance Neo|IMDA_NMR_100025 | Solution NMR | 1D 1H | 500 | cryogenic 5 mm TCI probe head | 298k | D2O | 3mm | topspin |
| Sr.No | First name | Last name | Organization | Designation | |
|---|---|---|---|---|---|
| 1 | Neel Sarovar | Bhavesh | neelsb@icgeb.res.in | International Centre for Genetic Engineering and Biotechnology, New Delhi | principal_investigator |
| 2 | Abhinav | Kumar | drabhinav1975@gmail.com | All India Institute of Medical Sciences Delhi, New Delhi | co_principal_investigator |
| 3 | Ramesh | Vaidyanathan | v17.ramesh@gmail.com | All India Institute of Medical Sciences Delhi, New Delhi | research_scholar |
| 4 | Arun Kumar | Malaisamy | makias191@gmail.com | International Centre for Genetic Engineering and Biotechnology, New Delhi | research_scholar |
| Sr.No | ftprun ID | NMR Exp ID | NMR Data Files |
|---|---|---|---|
| 1 | IMR_100066 | IME_100067 | c1.zip |
| 2 | IMR_100667 | IME_100068 | c10.zip |
| 3 | IMR_100668 | IME_100069 | c11.zip |
| 4 | IMR_100669 | IME_100070 | c12.zip |
| 5 | IMR_100670 | IME_100071 | c13.zip |
| 6 | IMR_100671 | IME_100072 | c14.zip |
| 7 | IMR_100672 | IME_100073 | c15.zip |
| 8 | IMR_100673 | IME_100074 | c16.zip |
| 9 | IMR_100674 | IME_100075 | c17.zip |
| 10 | IMR_100675 | IME_100076 | c18.zip |
| 11 | IMR_100676 | IME_100077 | c19.zip |
| 12 | IMR_100677 | IME_100078 | c2.zip |
| 13 | IMR_100678 | IME_100079 | c20.zip |
| 14 | IMR_100679 | IME_100080 | c21.zip |
| 15 | IMR_100680 | IME_100081 | c22.zip |
| 16 | IMR_100681 | IME_100082 | c23.zip |
| 17 | IMR_100682 | IME_100083 | c24.zip |
| 18 | IMR_100683 | IME_100084 | c25.zip |
| 19 | IMR_100684 | IME_100085 | c26.zip |
| 20 | IMR_100685 | IME_100086 | c27.zip |
| 21 | IMR_100686 | IME_100087 | c28.zip |
| 22 | IMR_100687 | IME_100088 | c29.zip |
| 23 | IMR_100688 | IME_100089 | c3.zip |
| 24 | IMR_100689 | IME_100090 | c30.zip |
| 25 | IMR_100690 | IME_100091 | c31.zip |
| 26 | IMR_100691 | IME_100092 | c32.zip |
| 27 | IMR_100692 | IME_100093 | c33.zip |
| 28 | IMR_100693 | IME_100094 | c34.zip |
| 29 | IMR_100694 | IME_100095 | c35.zip |
| 30 | IMR_100695 | IME_100096 | c36.zip |
| 31 | IMR_100696 | IME_100097 | c37.zip |
| 32 | IMR_100697 | IME_100098 | c38.zip |
| 33 | IMR_100698 | IME_100099 | c39.zip |
| 34 | IMR_100699 | IME_100100 | c4.zip |
| 35 | IMR_100700 | IME_100101 | c40.zip |
| 36 | IMR_100701 | IME_100102 | c41.zip |
| 37 | IMR_100702 | IME_100103 | c42.zip |
| 38 | IMR_100703 | IME_100104 | c43.zip |
| 39 | IMR_100704 | IME_100105 | c44.zip |
| 40 | IMR_100705 | IME_100106 | c45.zip |
| 41 | IMR_100706 | IME_100107 | c46.zip |
| 42 | IMR_100707 | IME_100108 | c47.zip |
| 43 | IMR_100708 | IME_100109 | c48.zip |
| 44 | IMR_100709 | IME_100110 | c49.zip |
| 45 | IMR_100710 | IME_100111 | c5.zip |
| 46 | IMR_100711 | IME_100112 | c50.zip |
| 47 | IMR_100712 | IME_100113 | c6.zip |
| 48 | IMR_100713 | IME_100114 | c7.zip |
| 49 | IMR_100714 | IME_100115 | c8.zip |
| 50 | IMR_100715 | IME_100116 | c9.zip |
| 51 | IMR_100716 | IME_100117 | n10d0.zip |
| 52 | IMR_100717 | IME_100118 | n10d1.zip |
| 53 | IMR_100718 | IME_100119 | n10d3.zip |
| 54 | IMR_100719 | IME_100120 | n11a.zip |
| 55 | IMR_100720 | IME_100121 | n11d1.zip |
| 56 | IMR_100721 | IME_100122 | n11d5.zip |
| 57 | IMR_100722 | IME_100123 | n12a.zip |
| 58 | IMR_100723 | IME_100124 | n12d1.zip |
| 59 | IMR_100724 | IME_100125 | n12d5.zip |
| 60 | IMR_100725 | IME_100126 | n13a.zip |
| 61 | IMR_100726 | IME_100127 | n13b.zip |
| 62 | IMR_100727 | IME_100128 | n13b2.zip |
| 63 | IMR_100728 | IME_100129 | n14a.zip |
| 64 | IMR_100729 | IME_100130 | n14b.zip |
| 65 | IMR_100730 | IME_100131 | n14c.zip |
| 66 | IMR_100731 | IME_100132 | n15a.zip |
| 67 | IMR_100732 | IME_100133 | n15b.zip |
| 68 | IMR_100733 | IME_100134 | n15c.zip |
| 69 | IMR_100734 | IME_100135 | n16d0.zip |
| 70 | IMR_100735 | IME_100136 | n16d1.zip |
| 71 | IMR_100736 | IME_100137 | n16d7.zip |
| 72 | IMR_100737 | IME_100138 | n17d1.zip |
| 73 | IMR_100738 | IME_100139 | n17d3.zip |
| 74 | IMR_100739 | IME_100140 | n17d5.zip |
| 75 | IMR_100740 | IME_100141 | n18a.zip |
| 76 | IMR_100741 | IME_100142 | n18b.zip |
| 77 | IMR_100742 | IME_100143 | n18c.zip |
| 78 | IMR_100743 | IME_100144 | n19a.zip |
| 79 | IMR_100744 | IME_100145 | n19b.zip |
| 80 | IMR_100745 | IME_100146 | n19c.zip |
| 81 | IMR_100746 | IME_100147 | n1a.zip |
| 82 | IMR_100747 | IME_100148 | n1b.zip |
| 83 | IMR_100748 | IME_100149 | n1c.zip |
| 84 | IMR_100749 | IME_100150 | n20d1.zip |
| 85 | IMR_100750 | IME_100151 | n20d3.zip |
| 86 | IMR_100751 | IME_100152 | n20d5.zip |
| 87 | IMR_100752 | IME_100153 | n21d1.zip |
| 88 | IMR_100753 | IME_100154 | n21d3.zip |
| 89 | IMR_100754 | IME_100155 | n21d7.zip |
| 90 | IMR_100755 | IME_100156 | n22d1.zip |
| 91 | IMR_100756 | IME_100157 | n22d3.zip |
| 92 | IMR_100757 | IME_100158 | n22d5.zip |
| 93 | IMR_100758 | IME_100159 | n23d1.zip |
| 94 | IMR_100759 | IME_100160 | n23d2.zip |
| 95 | IMR_100760 | IME_100161 | n23d7.zip |
| 96 | IMR_100761 | IME_100162 | n24d1.zip |
| 97 | IMR_100762 | IME_100163 | n24d3.zip |
| 98 | IMR_100763 | IME_100164 | n24d7.zip |
| 99 | IMR_100764 | IME_100165 | n2a.zip |
| 100 | IMR_100765 | IME_100166 | n2b.zip |
| 101 | IMR_100766 | IME_100167 | n2c.zip |
| 102 | IMR_100767 | IME_100168 | n3a.zip |
| 103 | IMR_100768 | IME_100169 | n3b.zip |
| 104 | IMR_100769 | IME_100170 | n3c.zip |
| 105 | IMR_100770 | IME_100171 | n4a.zip |
| 106 | IMR_100771 | IME_100172 | n4b.zip |
| 107 | IMR_100772 | IME_100173 | n4c.zip |
| 108 | IMR_100773 | IME_100174 | n5a.zip |
| 109 | IMR_100774 | IME_100175 | n5b.zip |
| 110 | IMR_100775 | IME_100176 | n5c.zip |
| 111 | IMR_100776 | IME_100177 | n7D1.zip |
| 112 | IMR_100777 | IME_100178 | n7d3.zip |
| 113 | IMR_100778 | IME_100179 | n7d5.zip |
| 114 | IMR_100779 | IME_100180 | n8d1.zip |
| 115 | IMR_100780 | IME_100181 | n8d3.zip |
| 116 | IMR_100781 | IME_100182 | n8d5.zip |
| 117 | IMR_100782 | IME_100183 | n9d1.zip |
| 118 | IMR_100783 | IME_100184 | n9d3.zip |
| 119 | IMR_100784 | IME_100185 | n9d5.zip |
| 120 | IMR_100785 | IME_100186 | p10d1.zip |
| 121 | IMR_100786 | IME_100187 | p10d2.zip |
| 122 | IMR_100787 | IME_100188 | p10d3.zip |
| 123 | IMR_100788 | IME_100189 | p11d1.zip |
| 124 | IMR_100789 | IME_100190 | p11d2.zip |
| 125 | IMR_100790 | IME_100191 | p11d3.zip |
| 126 | IMR_100791 | IME_100192 | p12d1.zip |
| 127 | IMR_100792 | IME_100193 | p12d2.zip |
| 128 | IMR_100793 | IME_100194 | p12d3.zip |
| 129 | IMR_100794 | IME_100195 | p14d2.zip |
| 130 | IMR_100795 | IME_100196 | p14d3.zip |
| 131 | IMR_100796 | IME_100197 | p14d7.zip |
| 132 | IMR_100797 | IME_100198 | p15d1.zip |
| 133 | IMR_100798 | IME_100199 | p15d2.zip |
| 134 | IMR_100799 | IME_100200 | p15d7.zip |
| 135 | IMR_100800 | IME_100201 | p16d1.zip |
| 136 | IMR_100801 | IME_100202 | p16d2.zip |
| 137 | IMR_100802 | IME_100203 | p16d3.zip |
| 138 | IMR_100803 | IME_100204 | p17d1.zip |
| 139 | IMR_100804 | IME_100205 | p17d2.zip |
| 140 | IMR_100805 | IME_100206 | p17d3.zip |
| 141 | IMR_100806 | IME_100207 | p18d1.zip |
| 142 | IMR_100807 | IME_100208 | p18d2.zip |
| 143 | IMR_100808 | IME_100209 | p18d3.zip |
| 144 | IMR_100809 | IME_100210 | p19d1.zip |
| 145 | IMR_100810 | IME_100211 | p19d2.zip |
| 146 | IMR_100811 | IME_100212 | p19d7.zip |
| 147 | IMR_100812 | IME_100213 | p1d1.zip |
| 148 | IMR_100813 | IME_100214 | p1d2.zip |
| 149 | IMR_100814 | IME_100215 | p1d3.zip |
| 150 | IMR_100815 | IME_100216 | p20d1.zip |
| 151 | IMR_100816 | IME_100217 | p20d2.zip |
| 152 | IMR_100817 | IME_100218 | p20d7.zip |
| 153 | IMR_100818 | IME_100219 | p21d1.zip |
| 154 | IMR_100819 | IME_100220 | p21d2.zip |
| 155 | IMR_100820 | IME_100221 | p21d3.zip |
| 156 | IMR_100821 | IME_100222 | p23d1.zip |
| 157 | IMR_100822 | IME_100223 | p23d2.zip |
| 158 | IMR_100823 | IME_100224 | p23d5.zip |
| 159 | IMR_100824 | IME_100225 | p24d1.zip |
| 160 | IMR_100825 | IME_100226 | p24d2.zip |
| 161 | IMR_100826 | IME_100227 | p24d7.zip |
| 162 | IMR_100827 | IME_100228 | p25d1.zip |
| 163 | IMR_100828 | IME_100229 | p25d2.zip |
| 164 | IMR_100829 | IME_100230 | p25d3.zip |
| 165 | IMR_100830 | IME_100231 | p26d1.zip |
| 166 | IMR_100831 | IME_100232 | p26d2.zip |
| 167 | IMR_100832 | IME_100233 | p26d3.zip |
| 168 | IMR_100833 | IME_100234 | p27d1.zip |
| 169 | IMR_100834 | IME_100235 | p27d2.zip |
| 170 | IMR_100835 | IME_100236 | p27d7.zip |
| 171 | IMR_100836 | IME_100237 | p28d1.zip |
| 172 | IMR_100837 | IME_100238 | p28d2.zip |
| 173 | IMR_100838 | IME_100239 | p28d3.zip |
| 174 | IMR_100839 | IME_100240 | p29d1.zip |
| 175 | IMR_100840 | IME_100241 | p29d2.zip |
| 176 | IMR_100841 | IME_100242 | p29d3.zip |
| 177 | IMR_100842 | IME_100243 | p2d1.zip |
| 178 | IMR_100843 | IME_100244 | p2d2.zip |
| 179 | IMR_100844 | IME_100245 | p2d3.zip |
| 180 | IMR_100845 | IME_100246 | p30d1.zip |
| 181 | IMR_100846 | IME_100247 | p30d2.zip |
| 182 | IMR_100847 | IME_100248 | p30d3.zip |
| 183 | IMR_100848 | IME_100249 | p31d1.zip |
| 184 | IMR_100849 | IME_100250 | p31d2.zip |
| 185 | IMR_100850 | IME_100251 | p31d3.zip |
| 186 | IMR_100851 | IME_100252 | p32d1.zip |
| 187 | IMR_100852 | IME_100253 | p32d2.zip |
| 188 | IMR_100853 | IME_100254 | p32d3.zip |
| 189 | IMR_100854 | IME_100255 | p3d1.zip |
| 190 | IMR_100855 | IME_100256 | p3d2.zip |
| 191 | IMR_100856 | IME_100257 | p3d3.zip |
| 192 | IMR_100857 | IME_100258 | p4d1.zip |
| 193 | IMR_100858 | IME_100259 | p4d2.zip |
| 194 | IMR_100859 | IME_100260 | p4d3.zip |
| 195 | IMR_100860 | IME_100261 | p7ad1.zip |
| 196 | IMR_100861 | IME_100262 | p7ad2.zip |
| 197 | IMR_100862 | IME_100263 | p7ad7.zip |
| 198 | IMR_100863 | IME_100264 | p7d1.zip |
| 199 | IMR_100864 | IME_100265 | p7d2.zip |
| 200 | IMR_100865 | IME_100266 | p7d3.zip |
Download Metabolite/Compound
| Sr.No | Structure | Details |
|---|